GGrantIndex
Sort

40,608 grants matching prostate cancer

NOVEL REGULATION AND ONCOGENIC MECHANISMS OF FATTY ACID SYNTHASE (FASN) IN AGGRESSIVE PROSTATE CANCER

$856,654
The University Of Texas Health Science Center At San Antonio · · FY2017 · Department of the Army

Chromosome Instability Drives Metal-Induced Lung Cancer

$856,452
John Pierce Wise · University Of Louisville · R35 · FY2025 · ES

Chromosome Instability Drives Metal-Induced Lung Cancer

$856,445
John Pierce Wise · University Of Louisville · R35 · FY2024 · ES

Chromosome Instability Drives Metal-Induced Lung Cancer

$856,425
John Pierce Wise · University Of Louisville · R35 · FY2022 · ES

Chromosome Instability Drives Metal-Induced Lung Cancer

$856,424
John Pierce Wise · University Of Louisville · R35 · FY2023 · ES

Novel Targets for Vaccine Therapy

$856,385
Claudia Palena · Division Of Basic Sciences - Nci · ZIC · FY2016 · CA

RELEASING THE FULL POTENTIAL OF DNA REPAIR INHIBITION IN PROSTATE CANCER

$855,931
Klinikum Rechts Der Isar Der Tu Munchen · · FY2022 · Defense Health Agency

Molecular prediction of myeloma in African Americans

$855,498
Irene M. Ghobrial · Dana-Farber Cancer Inst · U01 · FY2023 · CA

Clinical Nursing and Data Management Core

$855,395
William Marston Linehan · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA

CELL SIGNALING IN PROSTATE CANCER PROGRESSION

$855,303
University Of Virginia Charlottesville · P01 · FY2000 · CA

SELENIUM BASED CHEMOPREVENTION

$855,200
Cancer Therapy And Research Center · U01 · FY2002 · CA

BIOMARKER VALIDATION LABORATORIES

$855,137
University Of Alabama At Birmingham · U24 · FY2002 · CA

COMPREHENSIVE MOLECULAR PROFILING OF PROSTATE CANCER IN AFRICAN AMERICAN POPULATION: UNRAVELING MOLECULAR HETEROGENEITY

$855,122
Indiana University Of Pennsylvania · · FY2016 · Department of the Army

Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways

$854,717
Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion

$854,717
Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA

Morphologic, Metabolic and Functional Prostate Imaging

$854,691
Daniel B Vigneron · University Of California, San Francisco · R01 · FY2009 · CA

ANIBAMINE AND ITS ANALOGUES AS NOVEL ANTI-PROSTATE CANCER AGENTS

$854,601
Brigham & Womens Hospital Inc · · FY2008 · Department of the Army

Genetic Epidemiology of Telomere Maintenance and Cancer Etiology

$854,568
Sharon A. Savage · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA

GENE EXPRESSION ANALYSIS OF PROSTATE &LUNG CANCER

$854,560
Dana-Farber Cancer Institute · U01 · FY2000 · CA

SHCC MU NCORP

$854,438
Thomas Lad · Hektoen Institute For Medical Research · UG1 · FY2017 · CA

Expanding resources for understanding the genetic basis for prostate cancer in Af

$854,335
Christopher Alan Haiman · University Of Southern California · RC2 · FY2010 · CA

Mechanisms of microenvironment mediated resistance to cancer cell surface targeted therapeutics

$854,255
David J Beebe · University Of Wisconsin-Madison · UG3 · FY2021 · CA

A Stakeholder Informed Randomized Trial of Pretest Video Education vs Standard Genetic Counseling for Cancer Patients: Evaluating the Impact on Patients, Providers and Practices

$854,202
Huma Q Rana · Dana-Farber Cancer Inst · R01 · FY2021 · HG

INTEGRATIVE MOLECULAR CHARACTERIZATION AND BIOMARKER VALIDATION IN METASTATIC HORMONE-SENSITIVE PROSTATE CANCER (MHSPC)

$854,195
University Of Melbourne · · FY2021 · Department of the Army

TARGETING THE DYSREGULATION OF ADIPONECTIN AS A NOVEL PROSTATE CANCER THERAPY

$853,896
Queensland University Of Technology · · FY2020 · Defense Health Agency